Federal contract award
75N93021F00002
INVESTIGATION AND OPTIMIZATION OF FG-960 PRECLINICAL FORMULATIONS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | 75N93018D00001 |
| Set-aside | Not reported |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $218.6K |
| Current contract value | $218.6K |
| Potential contract value / ceiling | $218.6K |
| Start date | Feb 1, 2021 |
| Current end date | Sep 30, 2021 |
| Potential end date | Sep 30, 2021 |
| Latest award activity | Aug 10, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 10, 2026 | P00002 | $-19.0K | TO ADMINISTRATE DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS. |
| Jun 14, 2021 | P00001 | $0 | INVESTIGATION AND OPTIMIZATION OF FG-960 PRECLINICAL FORMULATIONS |
| Jan 28, 2021 | 0 | $237.6K | INVESTIGATION AND OPTIMIZATION OF FG-960 PRECLINICAL FORMULATIONS |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.